This was similar in other malignancies, including breast cancer ([26]) and lung adenocarcinoma ([28]), while other studies found TYK2 overexpression to be related to worse survival, e.g., in stomach adenocarcinoma ([29]). The gene discussed is TYK2; the disease is gastric adenocarcinoma.